Advertisement

Normal Tissue Effects Following 1- vs 3-Week Axillary Radiotherapy for Breast Cancer
Posted: 07/07/2025 | By: Chase Doyle

The nodal sub-study of the phase III FAST-Forward trial, published in Science Direct, investigated whether a 1-week schedule of 26 Gy in 5 fractions is safe for patients receiving adjuvant axillary radiotherapy for breast cancer.

Question 1 of 5

What was the primary endpoint of the FAST-Forward nodal sub-study?

Choose 1

A
Clinician-reported breast lymphedema at 5 years
B
Patient-reported moderate or marked arm or hand swelling at 5 years
C
Local recurrence rates at 5 years
D
Sensorimotor symptoms reported by investigators

CategoriesView All Quizzes

Tumor Type


Additional Topics



Conference Coverage